The association of CXCR2 with NET formation has been documented, as demonstrated by a significant reduction in NET formation in neutrophils from individuals with chronic obstructive pulmonary disease (COPD) following treatment with a selective CXCR2 antagonist [46]. The gene discussed is CXCR2; the disease is chronic obstructive pulmonary disease.